A CONCISE REVIEW OF THE COST-EFFECTIVENESS OF CORONARY HEART DISEASE PREVENTION
Open Access
- 1 January 2000
- journal article
- review article
- Published by Elsevier in Medical Clinics of North America
- Vol. 84 (1) , 279-297
- https://doi.org/10.1016/s0025-7125(05)70219-4
Abstract
No abstract availableKeywords
This publication has 77 references indexed in Scilit:
- Direct Medical Costs of Coronary Artery Disease in the United StatesThe American Journal of Cardiology, 1998
- Cost-Effectiveness of Pravastatin in Secondary Prevention of Coronary Artery DiseaseThe American Journal of Cardiology, 1996
- Combined use of aspirin and warfarin in primary prevention of ischemic heart disease in men at high riskThe American Journal of Cardiology, 1995
- Economic evaluation of cardiac rehabilitation soon after acute myocardial infarctionThe American Journal of Cardiology, 1993
- Economics of a reduction in smoking: case study from Heartbeat Wales.Journal of Epidemiology and Community Health, 1993
- An economic evaluation of lovastatin for cholesterol lowering and coronary artery disease reductionThe American Journal of Cardiology, 1991
- Cost-effectiveness perspectives in coronary heart diseaseAmerican Heart Journal, 1990
- Clinical benefits and cost-effectiveness of lowering serum cholesterol levels: The case of simvastatin and cholestyramine in The NetherlandsThe American Journal of Cardiology, 1990
- Treatment of hypertension and its effect on cardiovascular risk factors: data from the Framingham Heart Study.Circulation, 1985
- Case Mix, Costs, and OutcomesNew England Journal of Medicine, 1984